EX-99.1 2 dex991.htm PRESS RELEASE Press release

Exhibit 99.1

 

August 26, 2004

 

Patterson Companies Reports Higher First Quarter Sales and Earnings

 

St. Paul, MN—August 26, 2004—Patterson Companies, Inc. (Nasdaq NMS: PDCO) today reported consolidated sales of $577,943,000 for the first quarter of fiscal 2005 ended July 31, an increase of 33% from $433,262,000 in the year-earlier quarter. Sales for the current quarter include contributions from four acquisitions and the impact of an extra or fourteenth week in the first quarter, which will make fiscal 2005 a 53-week year ending on April 30, 2005. Net income increased 39% to $40,815,000 or $0.59 per diluted share, from $29,393,000 or $0.43 per diluted share in the first quarter of fiscal 2004. The acquisition of AbilityOne Products Corp. in last year’s second quarter continued having a significant positive impact on consolidated earnings, but as previously forecasted, the three most recent transactions, which were completed near the end of fiscal 2004, had a minimal impact on consolidated first quarter earnings. The majority of the earnings contribution from these latter three acquisitions is anticipated during the second half of fiscal 2005.

 

The Patterson Dental Supply unit, Patterson’s largest business, reported sales growth of 14% to $425,617,000 in the first quarter. The May 2004 acquisition of CAESY Education Systems, Inc. and the estimated impact of the extra week contributed six percentage points of first quarter sales growth.

 

Sales of consumable dental supplies and printed office products increased 14% in the first quarter, led by U.S. consumables growth of 15%. All consumable sales growth was internally generated, while the extra week in this year’s first quarter accounted for an estimated eight percentage points of the U.S. sales increase. The resulting 7% internal sales growth rate for U.S. consumables reflects the positive impact of the strengthened focus placed on this portion of Patterson’s business during the past year. Reflecting this renewed emphasis, 42 field representatives were added during the first quarter, bringing Patterson’s dental sales force to approximately 1,400 at July 31.

 

Sales of dental equipment and software rose 17% in the first quarter. Substantially all of this growth was internally generated. It is difficult to measure the impact of an extra week on equipment sales due to such factors as the length of time from initial order to installation, a period that can span several months.

 

Sales of other services and products, consisting primarily of parts, technical service, software support, and insurance e-claims, increased 12% in the first quarter, which includes the impact of acquisitions and the extra week.

 

AbilityOne Products Corp., which was acquired in September 2003, reported sales of $77,245,000, which includes the May 2004 acquisition of Medco Supply Company, Inc. and the impact of the extra week. Excluding these items, AbilityOne’s first quarter sales increased 6% on a pro forma basis, which was consistent with expectations.

 

Sales of the Webster Veterinary Supply unit increased 22% in the first quarter to $75,081,000. The positive impact of the April 2004 acquisition of ProVet and the extra week offset the conversion of a temporary pharmaceutical distribution agreement into an agency arrangement in last year’s third quarter. After adjusting for these factors, Webster’s internal sales were unchanged in this year’s first quarter.

 

Peter L. Frechette, chairman and chief executive officer, commented: “We are particularly encouraged by the strong growth of dental consumable supplies in this year’s first quarter. As we have reported throughout the past year, we have focused considerable resources on strengthening this portion of our dental business, and the 7% rate of internal sales growth marked the third consecutive quarter of improving U.S. consumables sales. Our first quarter results also


benefited from the continuation of solid demand for basic and new-technology dental equipment and related software, as well as from the sales contributions from recent acquisitions, which have strengthened the market positions of our dental, veterinary and rehabilitation supply businesses.”

 

Frechette continued: “We are confident that the appropriate plans and strategies are in place to ensure the continued success of this organization. At this stage, the second quarter is shaping up as another good period for Patterson, and we are forecasting earnings of $0.62 to $0.64 per diluted share for this period. We also reiterate our previously issued financial guidance of $2.68 to $2.72 for full-year fiscal 2005.”

 

About Patterson Companies, Inc.

 

Patterson Companies, Inc. is a value-added distributor serving the dental, companion-pet veterinarian and rehabilitation supply markets.

 

Dental Market

 

As Patterson’s largest business, Patterson Dental Supply provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions and value-added services to dentists and dental laboratories throughout North America.

 

Veterinary Market

 

Webster Veterinary Supply is the nation’s second largest distributor of consumable veterinary supplies, equipment, diagnostic products, vaccines and pharmaceuticals to companion-pet veterinary clinics.

 

Rehabilitation Market

 

AbilityOne Products Corp. is the world’s leading distributor of rehabilitation supplies and non-wheelchair assistive patient products to the physical and occupational therapy markets. The unit’s global customer base includes hospitals, long-term care facilities, clinics and dealers.

 

#     #     #

 

This release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are information of a non-historical nature and are subject to risks and uncertainties that are beyond the Company’s ability to control. The Company cautions shareholders and prospective investors that the following factors, among others, may cause actual results to differ materially from those indicated by the forward-looking statements: competition within the dental, veterinary, and rehabilitative and assistive living supply industries; changes in the economics of dentistry, including reduced growth in expenditures by private dental insurance plans, the effects of economic conditions and the effects of healthcare reform, which may affect future per capita expenditures for dental services and the ability and willingness of dentists to invest in high-technology products; the effects of healthcare related legislation and regulation which may affect expenditures or reimbursements for rehabilitative and assistive products; changes in the economics of the veterinary supply market, including reduced growth in per capita expenditures for veterinary services and reduced growth in the number of households owning pets; the ability of the Company to maintain satisfactory relationships with its sales force; unforeseen operating risks; risks associated with the dependence on manufacturers of the Company’s products; and the ability of the Company to successfully integrate the recent acquisitions into its existing business. Forward-looking statements are qualified in their entirety by the cautionary language set forth in the Company’s filings with the Securities and Exchange Commission.

 

For additional information contact:

    

R. Stephen Armstrong

  

Richard G. Cinquina

Executive Vice President & CFO

  

Equity Market Partners

651/686-1600

  

904/261-2210 or 800/522-1744


Patterson Companies, Inc.

Add -3-

 

PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except for earnings per share)

(Unaudited)

 

     Quarter Ended

 
    

July 31,

2004


   

July 26,

2003


 

Net sales

   $ 577,943     $ 433,262  

Gross profit

     203,969       144,582  

Operating expenses

     136,367       99,573  
    


 


Operating income

     67,602       45,009  

Other (expense) income, net

     (2,396 )     2,093  
    


 


Income before taxes

     65,206       47,102  

Income taxes

     24,391       17,709  
    


 


Net income

   $ 40,815     $ 29,393  
    


 


Earnings per share:

                

Basic

   $ 0.60     $ 0.43  

Diluted

   $ 0.59     $ 0.43  

Shares:

                

Basic

     68,261       67,838  

Diluted

     69,304       68,430  

Gross margin

     35.3 %     33.4 %

Operating expenses as a % of net sales

     23.6 %     23.0 %

Operating income as a % of net sales

     11.7 %     10.4 %

Effective tax rate

     37.4 %     37.6 %

Return on net sales

     7.1 %     6.8 %

 

-more-


Patterson Companies, Inc.

Add -4-

 

PATTERSON COMPANIES, INC.

SUPPLEMENTARY FINANCIAL DATA

(In thousands)

(Unaudited)

 

     Quarter Ended

 
    

July 31,

2004


   

July 26,

2003


 

Consolidated Net Sales

                

Consumable and printed products

   $ 389,863     $ 281,394  

Equipment and software

     144,984       116,570  

Other

     43,096       35,298  
    


 


Total

   $ 577,943     $ 433,262  
    


 


Rehabilitative Supply

                

Actual

                

Consumable and printed products

   $ 65,529     $ —    

Equipment

     8,257       —    

Other

     3,459       —    
    


 


Total

   $ 77,245     $ —    
    


 


Proforma

   $ 77,245     $ 56,402  (a)
    


 


Veterinary Supply

                

Consumable and printed products

   $ 71,207     $ 58,774  

Equipment

     2,642       1,579  

Other

     1,232       1,097  
    


 


Total

   $ 75,081     $ 61,450  
    


 


Other (Expense) Income, net

                

Interest income

   $ 1,321     $ 1,898  

Interest expense

     (3,758 )     (32 )

Other

     41       227  
    


 


     $ (2,396 )   $ 2,093  
    


 



(a) Proforma basis, as if the acquisition of AbilityOne had occurred at the beginning of fiscal 2004, but does not give effect to the recent Medco acquisition.

 

-more-


Patterson Companies, Inc.

Add -5-

 

PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in thousands)

 

    

July 31,

2004


   April 24,
2004


     (Unaudited)     

ASSETS

             

Current assets:

             

Cash and short-term investments

   $ 298,255    $ 295,178

Receivables, net

     258,421      285,249

Inventory

     191,587      173,022

Prepaid expenses and other current assets

     28,246      24,694
    

  

Total current assets

     776,509      778,143

Property and equipment, net

     83,917      77,233

Goodwill and other intangible assets

     739,534      698,217

Other

     36,385      35,364
    

  

Total Assets

   $ 1,636,345    $ 1,588,957
    

  

LIABILITIES AND STOCKHOLDERS’ EQUITY

             

Current liabilities:

             

Accounts payable

   $ 154,028    $ 149,528

Other accrued liabilities

     96,697      94,129

Current maturities of long-term debt

     20,031      20,031
    

  

Total current liabilities

     270,756      263,688

Long-term debt

     471,549      479,556

Other non-current liabilities

     43,955      43,955
    

  

Total liabilities

     786,260      787,199

Stockholders’ equity

     850,085      801,758
    

  

Total Liabilities and Stockholders’ Equity

   $ 1,636,345    $ 1,588,957
    

  

 

-more-


Patterson Companies, Inc.

Add -6-

 

PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(Dollars in thousands)

(Unaudited)

 

     Three Months Ended

 
     July 31,
2004


    July 26,
2003


 

Operating activities:

                

Net income

   $ 40,815     $ 29,393  

Depreciation & amortization

     6,449       3,491  

Change in assets and liabilities, net of acquired

     18,207       23,446  
    


 


Net cash provided by operating activities

     65,471       56,330  

Investing activities:

                

Additions to property and equipment, net

     (8,100 )     (2,172 )

Acquisitions

     (52,856 )     —    

(Purchase) Sale of investments

     (1,939 )     1,474  
    


 


Net cash used in investing activities

     (62,895 )     (698 )

Net cash used in financing activities

     (1,438 )     2,397  
    


 


Net increase in cash and cash equivalents

   $ 1,138     $ 58,029